Bioceltix SA (BCXP)

Currency in PLN
82.00
-0.70(-0.85%)
Closed·
BCXP is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
81.0082.70
52 wk Range
73.00129.00
Key Statistics
Bid/Ask
82.00 / 82.30
Prev. Close
82.7
Open
82.7
Day's Range
81-82.7
52 wk Range
73-129
Volume
4.83K
Average Volume (3m)
8.28K
1-Year Change
-1.0856%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BCXP Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
133.00
Upside
+62.20%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts do not anticipate the company will be profitable this year

Bioceltix SA News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Buy

Bioceltix SA Company Profile

Bioceltix S.A. engages in the development of stem cell-based biopharmaceuticals for veterinary use. The company’s products include BCX-CM-J, a stem-cell based biological drug for the treatment of osteoarthritis in dogs; BCX-CM-AD, a drug candidate based on allogeneic stem cells for the treatment of atopic dermatitis in dogs; and BCX-EM, a drug candidate based on allogeneic mesenchymal stem cells for the treatment of arthritis in horses. The company was founded in 2016 and is headquartered in Wroclaw, Poland.

Employees
41
Market
Poland

Compare BCXP to Peers and Sector

Metrics to compare
BCXP
Peers
Sector
Relationship
P/E Ratio
−27.3x−5.3x−0.6x
PEG Ratio
−1.110.010.00
Price/Book
15.0x2.5x2.6x
Price / LTM Sales
-6.0x3.4x
Upside (Analyst Target)
62.2%25.5%41.1%
Fair Value Upside
Unlock−0.5%5.3%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 133.00
(+62.20% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
Nov 28, 2025
EPS / Forecast
-0.89 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

BCXP Income Statement

People Also Watch

300.00
SNTP
+1.97%
211.00
CBF
+1.93%
149.80
RBW
-1.25%
196.20
DIAP
+0.59%
3,790.00
BFT
+1.07%

FAQ

What Is the Bioceltix (BCXP) Stock Price Today?

The Bioceltix stock price today is 82.00

What Stock Exchange Does Bioceltix Trade On?

Bioceltix is listed and trades on the Warsaw Stock Exchange stock exchange.

What Is the Stock Symbol for Bioceltix?

The stock symbol for Bioceltix is "BCXP."

What Is the Bioceltix Market Cap?

As of today, Bioceltix market cap is 403.81M.

What Is Bioceltix's Earnings Per Share (TTM)?

The Bioceltix EPS (TTM) is -2.89.

When Is the Next Bioceltix Earnings Date?

Bioceltix will release its next earnings report on Feb 25, 2026.

From a Technical Analysis Perspective, Is BCXP a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Bioceltix Stock Split?

Bioceltix has split 0 times.

How Many Employees Does Bioceltix Have?

Bioceltix has 41 employees.

What is the current trading status of Bioceltix (BCXP)?

As of Jan 18, 2026, Bioceltix (BCXP) is trading at a price of 82.00, with a previous close of 82.70. The stock has fluctuated within a day range of 81.00 to 82.70, while its 52-week range spans from 73.00 to 129.00.

What Is Bioceltix (BCXP) Price Target According to Analysts?

The average 12-month price target for Bioceltix is PLN133, with a high estimate of PLN133 and a low estimate of PLN133. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +62.20% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.